Skip to search formSkip to main contentSkip to account menu

Zometa

Known as: Novartis brand of zoledronic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
hallmark of of the of the to foreign as a consequence of the primary tumor. Malignant cells from the primary to they conventional… 
Highly Cited
2014
Highly Cited
2014
Aging skeletal muscle is associated with not only a reduction in muscle size and strength but also in muscle quality which… 
Highly Cited
2011
2009
2009
Drs. Lisa Schwartz and Steven Woloshin write that much critical information that the FDA has at the time of approval may fail to… 
Highly Cited
2007
Highly Cited
2007
PURPOSE Treatment with aromatase inhibitors decreases bone mineral density (BMD) and may increase the risk of fractures in… 
Highly Cited
2003
Highly Cited
2003
BACKGROUND Renal failure and toxic acute tubular necrosis (ATN) may be seen following exposure to a variety of therapeutic agents… 
Highly Cited
2002
Highly Cited
2002
Bisphosphonates (BPs) are pyrophosphate analogues in which the oxygen in P-O-P has been replaced by a carbon, resulting in a… 
Review
2002
Review
2002
Bisphosphonates are the treatment of choice for lytic bone lesions associated with breast cancer. In contrast, bone lesions…